Wendy Dwyer has joined Surface Oncology (NASDAQ: SURF) as chief business officer, the same role she had most recently at privately held Portal Instruments. Her experience also include positions at AstraZeneca (NYSE: AZN) and Ipsen Biosciences. Cambridge, MA-based Surface, which went public last year, is developing cancer immunotherapies.
UNDERWRITERS AND PARTNERS
